Posted by Michael Wonder on 11 Apr 2023
Cancer drug shortages are creating dire circumstances for some patients
11 April 2023 - Robert Landfair, 76, was diagnosed with Stage 4 prostate cancer in 2018.
After several unsuccessful rounds of chemotherapy, his doctor, Alan Tan of Rush University Medical Center in Chicago, recommended that he switch to Pluvicto, a new medication for advanced prostate cancer.
But the drug’s manufacturer, Novartis, has had supply problems. Landfair is now on a waitlist for the medication, which isn’t expected to be widely available for several more months.
